News & Events

Filter By:
29 November
2023
Inspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
Read More
16 November
2023
Inspira™ Technologies Reports Third Quarter 2023 Financial Results
Read More
06 November
2023
Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology
Read More
25 October
2023
Inspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical Device
Read More
24 October
2023
Inspira™ Terminates ATM Program and Provides an Update
Read More
10 October
2023
Inspira™ Enters into a Distribution Agreement in Central America with CIO MED GROUP
Read More
13 September
2023
Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization
Read More
31 August
2023
Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices
Read More
10 August
2023
Inspira™ Technologies Reports Second Quarter 2023 Financial Results
Read More
09 August
2023
INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.
Read More
24 July
2023
Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval
Read More
19 July
2023
Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.
Read More
15 June
2023
Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care
Read More
30 May
2023
Inspira Technologies Appoints Dr. Nir as Chief Medical Officer
Read More
18 May
2023
Inspira™ Technologies Reports First Quarter 2023 Financial Results
Read More
16 May
2023
Inspira™ Technologies will Reveal the New ALICE™ Device at the World’s Largest Extracorporeal Life Support Conference
Read More
11 May
2023
Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
Read More
04 April
2023
Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results
Read More
22 March
2023
Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study
Read More
10 March
2023
VP operations presents the start of ALICE™ Device manufacturing
Read More
13 February
2023
Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor
Read More
23 January
2023
Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System’s Convertible Dual Lumen Cannula Device and Method of Use
Read More
10 January
2023
Diamond Equity Research Initiates Coverage on Inspira Technologies Ltd. (NASDAQ: IINN)
Read More
04 January
2023
Creating a Paradigm Shift in Respiratory Care: Early Respiratory Support Reducing the Need for Invasive Mechanical Ventilation / by HAARETZ
Read More
27 December
2022
Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
Read More
25 December
2022
VP clinical affairs video presents the upcoming clinical trial in Sheba hospital
Read More
20 December
2022
Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, Ahead of Planned 2023 FDA Submission
Read More
14 December
2022
Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor
Read More
23 November
2022
Inspira™ Technologies Reports Third Quarter 2022 Financial Results
Read More
22 November
2022
Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 Million for Deployment of 1,364 HYLA™ Blood Sensors
Read More
10 November
2022
Inspira™ Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRA™ ART System
Read More
07 September
2022
Inspira™ Technologies Performed HYLA™ Blood Sensor In-Vivo Study, in Preparation of Planned Human Studies
Read More
01 September
2022
Inspira™ Technologies to Present at the H.C. Wainwright 24th Annual Global Investor Conference
Read More
11 August
2022
Inspira™ Technologies Reports Second Quarter 2022 Financial Results
Read More
07 July
2022
Inspira™ Technologies Signs Strategic Agreement in U.S. to potentially provide $59 million for Inspira for deployment of 3,889 HYLA™ Blood Sensors
Read More
06 July
2022
Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients – Potentially Targets $2.5 Billion ABG Market
Read More
08 June
2022
Inspira™ Technologies Strategically Plans to Actualize Hundreds of Millions in Conditional Distribution Agreements / by Benzinga
Read More
19 May
2022
Inspira™ Technologies Announces 2022 first Quarter Financial Results
Read More
03 May
2022
Inspira™ Technologies to Participate in Upcoming Events in May
Read More
27 April
2022
The Disruptive MedTech Company Aiming to Minimise Patients’ Need for Invasive Mechanical Ventilation Intervention / by Campden FB
Read More
06 April
2022
Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M
Read More
31 March
2022
Inspira Technologies Releases Q4 & FY2021 Financial Results
Read More
31 March
2022
Inspira Technologies Releases Q4 & FY2021 Financial Results – CEO Update
Read More
15 March
2022
Inspira Technologies will present its “artificial lungs” technology in front of family offices from all over the world
Read More
10 March
2022
Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure
Read More
28 February
2022
Inspira Technologies Is Awarded the 2021 Frost & Sullivan Technology Innovation Leadership Award
Read More
27 February
2022
Inspira Technologies – Awarded with the 2021 Frost & Sullivan Best Practices Technology Innovation Leadership Award
Read More
16 February
2022
The Respiratory Care Market – Factors Driving the Market and Opportunities for Inspira Technologies’ Products
Read More
10 February
2022
Inspira Technologies to Present at the Aegis Capital Corp. Virtual Conference
Read More
03 February
2022
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO)
Read More
31 January
2022
Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals
Read More
31 January
2022
Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period
Read More
28 January
2022
Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system
Read More
19 January
2022
Professor Daniel Brodie, Director of Critical Care from New-York Columbia – Presbyterian Hospital, Has Joined Inspira Technologies’ Advisory Board
Read More
09 December
2021
Inspira Technologies Signs Strategic Agreement with Innovimed
Read More
08 December
2021
Inspira Technologies Files a PCT Patent Application for its Flagship ART Device and Proprietary Method of Use
Read More
30 November
2021
Prof Eddy Fan has joined Inspira’s Scientific Advisory Board
Read More
23 November
2021
Third Quarter Financial Reports Results
Read More
23 November
2021
Inspira Technologies Announces 2021 Third Quarter Financial Results; In October 2021, Company increases cash balance by $9.4 Million due to investors Exercising Warrants
Read More
22 November
2021
Dr. Stephane Ledot, an Expert in Critical Care and Anesthesia, Has Joined Inspira Technologies’ Scientific Advisory Board
Read More
16 November
2021
Joe Hayon Presents at the H.C. Wainright 7th Annual Israel Conference
Read More
14 November
2021
Inspira to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference
Read More
10 November
2021
Inspira Technologies Files a PCT Patent Application for its Novel Dual Lumen Cannula Used for Blood Oxygenation
Read More
28 October
2021
Has COVID changed the game and what are the opportunities for Inspira’s ART device? Dr. Kassif, The Chairman of the Israeli ECMO Society
Read More
26 October
2021
Inspira Technologies Signs a Strategic Agreement With Waas Group
Read More
25 October
2021
“Millions May Soon Breath Better” – Inspira at Forbes
Read More
14 October
2021
Inspira Technologies to Present In-Person at the HLTH Conference in Boston
Read More
30 September
2021
Inspira Technologies to Host COVID-19 Virtual Conference on October 6
Read More
22 September
2021
Inspira Technologies’ “Artificial Lung” to Acquire a Digital Edge: The Company Contracted GlobalLogic, a Hitachi Group Company, for Advanced Digital Product Engineering Services
Read More
22 September
2021
Inspira Technologies’ “Artificial Lung” To Acquire A Digital Edge: The Company Contracted GlobalLogic, A Hitachi Group Company, For Advanced Digital Product Engineering Services
Read More
15 September
2021
Inspira Technologies Files a Patent Application for a Supportive Device to be Utilized with the ART Device
Read More
12 September
2021
Listen To Joe Hayon, Inspira-Technologies’ President, CFO & Co-Founder, Sharing Inspira’s Sharing The Company’s Go-To-Market Strategy
Read More
09 September
2021
Inspira Technologies to Participate in Upcoming Conferences in September
Read More
13 August
2021
Inspira Technologies Announces First Half 2021 Financial Results and Provides Business Update
Read More
10 August
2021
Inspira Technologies Expands Board of Directors to Accelerate Company’s Go-to-Market Efforts
Read More
10 August
2021
Low Flow Extracorporeal Oxygenation Approach Is The Future Of Acute Respiratory Care
Read More
06 August
2021
An Interview With Dagi Ben-Noon, CEO At Inspira Technologies
Read More
05 August
2021
Top 115 Medical And Healthcare Startups In Israel
Read More
02 August
2021
EXCLUSIVE: Inspira Aims To Replace Mechanical Ventilation With Augmented Respiratory Technology
Read More
26 July
2021
Inspira Expands Medical Advisory Board as Part of Future Expansion into North American Market
Read More
22 July
2021
10+ Best Healthcare Startups: Inspiration And Brave Findings Nearby
Read More
19 July
2021
Inspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent Blood Clotting in Inspira’s ART System
Read More
16 July
2021
Inspira Technologies Reached Important Milestone as It Completed a Pump Bench Study
Read More
16 July
2021
Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering
Read More
13 July
2021
Inspira Technologies OXY B.H.N. Ltd Announces Pricing of Initial Public Offering
Read More
28 June
2021
The Future Of Respiratory By Inspira Technologies: Breathing Without Lungs
Read More
16 June
2021
INSPIRA-Technologies Announces New Medical Advisory Board Member – Dr. Avraham Abutbul – Specialist in Internal Medicine, General Intensive Care Medicine and Pulmonary Medicine
Read More
20 May
2021
Inspira’s Proprietary Augmented Respiration Technology (ART)
Read More
14 April
2021
Q&A: An Intelligent Oxygenation System That Could Eliminate Need For Ventilators
Read More
31 March
2021
This IPO Stock Resembles Nanox, Is Inspira IINN Stock A Buy
Read More
29 March
2021
Breakthrough Oxygenation | Professor Benad Goldwasser
Read More
18 March
2021
Hillel’s Tech Corner: Inspira Makes Breathing Easy
Read More
04 March
2021
Inspira Technologies
Read More
24 February
2021
Inspira Technologies Appoints Benad Goldwasser As Chairman Of The Board
Read More
17 February
2021
Inspira Technologies and Sheba Medical Center Collaborate on Breakthrough Respiration Treatment
Read More
17 February
2021
Sheba And Inspira Technologies Implement Respiratory Treatment For Covid-19 Patients
Read More
10 December
2020
Inspira Technologies Reveals the AXT – An Intelligent System that Directly Oxygenates Blood for Respiratory Care
Read More
03 December
2020
Inspira Technologies Files U.S. Patent Application for its Innovative Respiratory Support Technology; Engages Leading U.S. Investment Bank for NASDAQ Listing
Read More

Get in Touch!

    Ha-Tidhar St 2, Ra'anana, Israel

    I consent to receive emails from Inspira Technologies Oxy B.H.N LTD. To request removal from the mailing list at any time, please send an email to info@inspirao2.com. You can find out about your rights and privacy choices, and how we use your information in our Privacy Policy.